Quick Takeaways
- This page summarizes Linda M. Richardson's Form 4 filing for INTERCEPT PHARMACEUTICALS, INC..
- 1 reported transaction and 0 derivative rows are listed below.
- Filing timestamp: 03 Sep 2021, 19:01.
Linda M. Richardson - 01 Sep 2021 Form 4 Insider Report for INTERCEPT PHARMACEUTICALS, INC.
- Signature
- /s/ Mary J. Grendell, as attorney-in-fact
- Issuer symbol
- N/A
- Transactions as of
- 01 Sep 2021
- Net transactions value
- -$12,341
- Form type
- 4
- Filing time
- 03 Sep 2021, 19:01:12 UTC
- Previous filing
- 16 Aug 2021
- Next filing
- 17 Nov 2021
- SEC
- View on sec.gov
Quoteable Key Fact
"Linda M. Richardson filed Form 4 for INTERCEPT PHARMACEUTICALS, INC. on 03 Sep 2021."
What Changed
- Previous filing in this sequence was filed on 16 Aug 2021.
- Current net transaction value: -$12,341.
Why This Matters
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Official SEC Source
Transactions Table
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | ICPT | Common Stock | Tax liability | $12,341 | -820 | -3.1% | $15.05 | 25,704 | 01 Sep 2021 | Direct | F1 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Explanation of Responses:
| Id | Content |
|---|---|
| F1 | Represents shares of common stock withheld by the Issuer to satisfy taxes associated with the partial vesting of a restricted stock unit award previously granted to the reporting person. |